These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35025607)

  • 1. miR-30a-5p inhibits the proliferation and collagen formation of cardiac fibroblasts in diabetic cardiomyopathy.
    Yang XX; Zhao ZY
    Can J Physiol Pharmacol; 2022 Feb; 100(2):167-175. PubMed ID: 35025607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-34a attenuates myocardial fibrosis in diabetic cardiomyopathy mice via targeting Pin-1.
    Zhang XL; Zhang G; Bai ZH
    Cell Biol Int; 2021 Mar; 45(3):642-653. PubMed ID: 33289184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apigenin suppresses TGF-β1-induced cardiac fibroblast differentiation and collagen synthesis through the downregulation of HIF-1α expression by miR-122-5p.
    Feng W; Ying Z; Ke F; Mei-Lin X
    Phytomedicine; 2021 Mar; 83():153481. PubMed ID: 33607460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of microRNA-150-5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose-treated cardiac fibroblasts.
    Che H; Wang Y; Li Y; Lv J; Li H; Liu Y; Dong R; Sun Y; Xu X; Zhao J; Wang L
    J Cell Physiol; 2020 Nov; 235(11):7769-7779. PubMed ID: 31710102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-142-5p and miR-212-5p cooperatively inhibit the proliferation and collagen formation of cardiac fibroblasts by regulating c-Myc/TP53INP1.
    Wang Z; Fu M; Li Y
    Can J Physiol Pharmacol; 2020 May; 98(5):314-323. PubMed ID: 32268073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-499-5p inhibits transforming growth factor-β1-induced Smad2 signaling pathway and suppresses fibroblast proliferation and collagen synthesis in rat by targeting TGFβ-R1.
    Zhao Q; Yang W; Li X; Yuan H; Guo J; Wang Y; Shan Z
    Mol Biol Rep; 2023 Dec; 50(12):9757-9767. PubMed ID: 37676431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
    Liu X; Guo B; Zhang W; Ma B; Li Y
    J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-21-3p triggers cardiac fibroblasts pyroptosis in diabetic cardiac fibrosis via inhibiting androgen receptor.
    Shi P; Zhao XD; Shi KH; Ding XS; Tao H
    Exp Cell Res; 2021 Feb; 399(2):112464. PubMed ID: 33385416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy.
    Yu M; Sun Y; Shan X; Yang F; Chu G; Chen Q; Han L; Guo Z; Wang G
    Cell Mol Biol Lett; 2022 Oct; 27(1):85. PubMed ID: 36209049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-145-5p attenuates hypertrophic scar via reducing Smad2/Smad3 expression.
    Shen W; Wang Y; Wang D; Zhou H; Zhang H; Li L
    Biochem Biophys Res Commun; 2020 Jan; 521(4):1042-1048. PubMed ID: 31732152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apigenin attenuates TGF-β1-stimulated cardiac fibroblast differentiation and extracellular matrix production by targeting miR-155-5p/c-Ski/Smad pathway.
    Wang F; Fan K; Zhao Y; Xie ML
    J Ethnopharmacol; 2021 Jan; 265():113195. PubMed ID: 32800930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-RNA 21Targets dual specific phosphatase 8 to promote collagen synthesis in high glucose-treated primary cardiac fibroblasts.
    Liu S; Li W; Xu M; Huang H; Wang J; Chen X
    Can J Cardiol; 2014 Dec; 30(12):1689-99. PubMed ID: 25418215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of circHIPK3 in the pathogenesis of diabetic cardiomyopathy in mice.
    Wang W; Zhang S; Xu L; Feng Y; Wu X; Zhang M; Yu Z; Zhou X
    Diabetologia; 2021 Mar; 64(3):681-692. PubMed ID: 33398455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of miR-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation.
    Li PF; He RH; Shi SB; Li R; Wang QT; Rao GT; Yang B
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30683806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-410-5p promotes the development of diabetic cardiomyopathy by suppressing PIM1-induced anti-apoptosis.
    Xia X; Liang Y; Zheng W; Lin D; Sun S
    Mol Cell Probes; 2020 Aug; 52():101558. PubMed ID: 32145290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal Downregulation of Caveolin-3 Mediates the Pro-Fibrotic Action of MicroRNA-22 in a Model of Myocardial Infarction.
    Zhang L; Yin H; Jiao L; Liu T; Gao Y; Shao Y; Zhang Y; Shan H; Zhang Y; Yang B
    Cell Physiol Biochem; 2018; 45(4):1641-1653. PubMed ID: 29486470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-30a regulates the atrial fibrillation-induced myocardial fibrosis by targeting snail 1.
    Yuan CT; Li XX; Cheng QJ; Wang YH; Wang JH; Liu CL
    Int J Clin Exp Pathol; 2015; 8(12):15527-36. PubMed ID: 26884822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-30b-5p and miR-22-3p restrain the fibrogenesis of post-myocardial infarction in mice via targeting PTAFR.
    Zhao XS; Ren Y; Wu Y; Ren HK; Chen H
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3993-4004. PubMed ID: 32329883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways.
    Zhang Y; Wang JH; Zhang YY; Wang YZ; Wang J; Zhao Y; Jin XX; Xue GL; Li PH; Sun YL; Huang QH; Song XT; Zhang ZR; Gao X; Yang BF; Du ZM; Pan ZW
    Sci Rep; 2016 Mar; 6():23010. PubMed ID: 26972749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA TUG1 Exacerbates Myocardial Fibrosis in Diabetic Cardiomyopathy by Modulating the microRNA-145a-5p/Cfl2 Axis.
    Wang K; Lin Y; Shen H; Yu S; Xu J
    J Cardiovasc Pharmacol; 2023 Mar; 81(3):192-202. PubMed ID: 36450139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.